Kobe Steel to Merge its Leadframe Stamping and Plating Operations

Effective October 1, 2002, Kobe Steel’s copper leadframe operation will merge with its subsidiary Leadmikk Ltd. The merged operation will be called Kobe Leadmikk Ltd and will be based in Fukuoka, Japan.

Kobe Steel currently produces copper sheet and strip and stamps it into leadframes for use in devices such as power transistors. Leadframes are the metal frames which semiconductor chips are placed and provide the electrical connections for the finished packaged devices. Leadmikk plates the leadframes, so the merger consolidates this aspect of Kobe’s business.

Kobe Steel will own 75% of Kobe Leadmikk, with the remaining 25% being owned by Metek Kitamura Co. Kobe Leadmikk will be involved with both the stamping and plating of the leadframes.

Kobe Leadmikk will be capitalised at 1.8 billion yen and will employ 250 people.

Kobe Steel has been involved in the leadframe business since 1984, when it established Leadmikk, with Metek Kitamura who were already involved with plating. The following year Kobe Steel established its leadframe stamping operation and has subsequently built another stamping plant in Singapore.

For More information on semiconductors, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kobe Steel. (2019, March 19). Kobe Steel to Merge its Leadframe Stamping and Plating Operations. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=247.

  • MLA

    Kobe Steel. "Kobe Steel to Merge its Leadframe Stamping and Plating Operations". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=247>.

  • Chicago

    Kobe Steel. "Kobe Steel to Merge its Leadframe Stamping and Plating Operations". AZoM. https://www.azom.com/news.aspx?newsID=247. (accessed November 21, 2024).

  • Harvard

    Kobe Steel. 2019. Kobe Steel to Merge its Leadframe Stamping and Plating Operations. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=247.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.